Anna R. Hemnes
About
Anna R. Hemnes is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology.
According to data from OpenAlex, Anna R. Hemnes has authored 222 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Pulmonary and Respiratory Medicine, 119 papers in Cardiology and Cardiovascular Medicine and 18 papers in Molecular Biology. Recurrent topics in Anna R. Hemnes's work include Pulmonary Hypertension Research and Treatments (193 papers), Cardiovascular Function and Risk Factors (74 papers) and Heart Failure Treatment and Management (30 papers). Anna R. Hemnes is often cited by papers focused on Pulmonary Hypertension Research and Treatments (193 papers), Cardiovascular Function and Risk Factors (74 papers) and Heart Failure Treatment and Management (30 papers). Anna R. Hemnes collaborates with scholars based in United States, Canada and United Kingdom. Anna R. Hemnes's co-authors include Ivan M. Robbins, James West, Hunter C. Champion, Evan L. Brittain, Meredith E. Pugh, John H. Newman, Paul M. Hassoun, Eric D. Austin, Stephen C. Mathai and Megha Talati and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.
In The Last Decade
Anna R. Hemnes
212 papers receiving 7.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anna R. Hemnes United States | 44 | 5.8k | 4.1k | 915 | 896 | 728 | 222 | 7.2k | ||
| Mardi Gomberg‐Maitland United States | 45 | 7.1k 1.2× | 5.2k 1.3× | 772 0.8× | 951 1.1× | 811 1.1× | 148 | 8.5k | ||
| Pascal de Groote France | 44 | 2.9k 0.5× | 3.9k 1.0× | 1.1k 1.2× | 1.0k 1.1× | 832 1.1× | 193 | 7.0k | ||
| James R. Klinger United States | 36 | 3.6k 0.6× | 2.3k 0.5× | 935 1.0× | 648 0.7× | 435 0.6× | 136 | 5.0k | ||
| Steeve Provencher Canada | 53 | 6.2k 1.1× | 3.4k 0.8× | 2.0k 2.2× | 874 1.0× | 617 0.8× | 187 | 8.3k | ||
| Laurent Savale France | 52 | 6.6k 1.1× | 3.4k 0.8× | 798 0.9× | 1.3k 1.5× | 736 1.0× | 251 | 8.3k | ||
| Seán Gaine Ireland | 38 | 6.8k 1.2× | 4.0k 1.0× | 1.0k 1.1× | 1.0k 1.2× | 665 0.9× | 143 | 8.2k | ||
| Joanna Pepke‐Żaba United Kingdom | 44 | 7.9k 1.4× | 4.9k 1.2× | 623 0.7× | 829 0.9× | 593 0.8× | 131 | 9.1k | ||
| Rolf M.F. Berger Netherlands | 49 | 6.0k 1.0× | 4.3k 1.0× | 1.0k 1.1× | 1.4k 1.6× | 3.2k 4.5× | 235 | 8.2k | ||
| Kelly Chin United States | 30 | 4.0k 0.7× | 2.8k 0.7× | 350 0.4× | 517 0.6× | 569 0.8× | 137 | 4.9k | ||
| Tomás Pulido Mexico | 28 | 5.9k 1.0× | 4.2k 1.0× | 381 0.4× | 630 0.7× | 785 1.1× | 93 | 6.5k |
Countries citing papers authored by Anna R. Hemnes
Since
Specialization
Citations
This map shows the geographic impact of Anna R. Hemnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna R. Hemnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna R. Hemnes more than expected).
Fields of papers citing papers by Anna R. Hemnes
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anna R. Hemnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna R. Hemnes. The network helps show where Anna R. Hemnes may publish in the future.
Co-authorship network of co-authors of Anna R. Hemnes
This figure shows the co-authorship network connecting the top 25 collaborators of Anna R. Hemnes. A scholar is included among the top collaborators of Anna R. Hemnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna R. Hemnes. Anna R. Hemnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Thompson, Patrick, Jeffrey Mewburn, Kimberly J. Dunham‐Snary, et al.. (2025). Circular RNA Profiling Identifies circ5078 as a BMPR2 -Derived Regulator of Endothelial Proliferation and Stress Responses. Arteriosclerosis Thrombosis and Vascular Biology. 45(9). 1546–1561.
2.
Kolaitis, Nicholas A., Jonathan Singer, Sonja Bartolome, et al.. (2025). The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry. The Journal of Heart and Lung Transplantation. 45(1). 125–136.
3.
Farber, Harrison W., Murali M. Chakinala, Anna R. Hemnes, et al.. (2025). Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity. Journal of Racial and Ethnic Health Disparities.
4.
Reddy, Yogesh N.V., Robert P. Frantz, Paul M. Hassoun, et al.. (2025). Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension. Circulation Heart Failure. 18(8). e012912–e012912.
5.
Hemnes, Anna R., Niki Fortune, Katherine Simon, et al.. (2024). A multimodal approach identifies lactate as a central feature of right ventricular failure that is detectable in human plasma. Frontiers in Medicine. 11. 1387195–1387195.
6.
Xia, Lu, Olivier Boucherat, Karthik Suresh, et al.. (2024). Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension. Circulation Heart Failure. 17(11). e012067–e012067.
7.
Weatherald, Jason, Anna R. Hemnes, Bradley A. Maron, et al.. (2024). Phenotypes in pulmonary hypertension. European Respiratory Journal. 64(3). 2301633–2301633.
8.
Reddy, Yogesh N.V., Robert P. Frantz, Paul M. Hassoun, et al.. (2024). Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension. Journal of the American College of Cardiology. 84(22). 2196–2210.
9.
Talati, Megha, Evan L. Brittain, Vineet Agrawal, et al.. (2023). A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific. Frontiers in Medicine. 10. 1276422–1276422.
10.
Martens, Pieter, Brett Larive, Barry A. Borlaug, et al.. (2023). Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications. European Heart Journal. 44(22). 1979–1991.
11.
Meegan, Jamie E., V. Eric Kerchberger, Niki Fortune, et al.. (2023). Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms. Pulmonary Circulation. 13(1). e12185–e12185.
12.
Akgün, Kathleen M., Remzi Bag, Vinicio de Jesús Pérez, et al.. (2023). Access to Medically Necessary Reproductive Care for Individuals with Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 208(3). 234–237.
13.
Smart, Charles D, Daniel J. Fehrenbach, Jean W. Wassenaar, et al.. (2023). Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure. Cardiovascular Research. 119(13). 2312–2328.
14.
Benza, Raymond L., David Langleben, Anna R. Hemnes, et al.. (2022). Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. European Respiratory Review. 31(166). 220061–220061.
15.
Garry, Jonah, Nicholas A. Kolaitis, Richard A. Kronmal, et al.. (2022). Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR). The Journal of Heart and Lung Transplantation. 41(12). 1808–1818.
16.
Yang, Bin, Tufik R. Assad, Jared O’Leary, et al.. (2018). Racial differences in patients referred for right heart catheterization and risk of pulmonary hypertension. Pulmonary Circulation. 8(2). 1–9.
17.
Hemnes, Anna R., Aaron W. Trammell, Stephen L. Archer, et al.. (2014). Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension. Circulation. 131(4). 401–409.
18.
Zhao, Min, Eric D. Austin, Anna R. Hemnes, James E. Loyd, & Zhongming Zhao. (2014). An evidence-based knowledgebase of pulmonary arterial hypertension to identify genes and pathways relevant to pathogenesis. Molecular BioSystems. 10(4). 732–740.
19.
Robbins, Ivan M., Anna R. Hemnes, Meredith E. Pugh, et al.. (2013). High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension. Circulation Heart Failure. 7(1). 116–122.
20.
Gebska, Milena A., Anna R. Hemnes, Trinity J. Bivalacqua, et al.. (2011). Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity. Cardiovascular Research. 90(2). 353–363.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mardi Gomberg‐Maitland Breakdown of academic impact, for papers by Pascal de Groote Breakdown of academic impact, for papers by James R. Klinger Breakdown of academic impact, for papers by Steeve Provencher Breakdown of academic impact, for papers by Laurent Savale Breakdown of academic impact, for papers by Seán Gaine Breakdown of academic impact, for papers by Joanna Pepke‐Żaba Breakdown of academic impact, for papers by Rolf M.F. Berger Breakdown of academic impact, for papers by Kelly Chin Breakdown of academic impact, for papers by Tomás Pulido